PON1 Human

Paraoxonase-1 Human Recombinant

Paraoxonase-1 Isoform Human Recombinant is expressed in E. coli, fused to a 4.5kDa amino terminal hexahistidine tag, having a total molecular weight of 42.9kDa.

The PON1 purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT21005
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.

PON1 Human, HEK

Paraoxonase-1 Human Recombinant, HEK

PON1 Human Recombinant produced in HEK cells is a single, glycosylated, polypeptide chain (16-355 a.a) containing a total of 346 amino acids, having a molecular mass of 39.0kDa.
PON1 is fused to a 6 amino acid His-tag at C-terminus,and is purified by proprietary chromatographic techniques.

Shipped with Ice Packs
Cat. No.
BT21094
Source

HEK293 Cells.

Appearance
Sterile Filtered colorless solution.

PON2 Human

Paraoxonase-2 Human Recombinant

Paraoxonase-2 Human Recombinant is expressed in E. coli having a molecular weight of 43.5 kDa and fused to an amino terminal hexahistidine tag.
The PON2 purified by proprietary chromatographic techniques.
Shipped with Ice Packs
Cat. No.
BT21161
Source
Escherichia Coli.
Appearance
Sterile Filtered clear solution.
Definition and Classification

Paraoxonases are a family of mammalian enzymes with aryldialkylphosphatase activity. There are three known paraoxonase isozymes: PON1, PON2, and PON3. These enzymes were initially identified for their role in hydrolyzing organophosphates, such as those found in insecticides . The genes encoding these enzymes are located on the long arm of chromosome 7 in humans .

Biological Properties

Key Biological Properties: Paraoxonases exhibit esterase and lactonase activities, with a broad substrate specificity . They are involved in hydrolyzing a variety of substrates, including lactones and aryl esters .

Expression Patterns: PON1 is primarily expressed in the liver but is also found in the kidney and colon . PON2 is ubiquitously expressed in various tissues, including the brain, lungs, and small intestine . PON3 is expressed in the liver and associated with high-density lipoprotein (HDL) in the bloodstream .

Tissue Distribution: PON1 is synthesized in the liver and transported into the bloodstream, where it associates with HDL . PON2 is found in many tissues, including the brain, lungs, heart, and liver . PON3 is present in HDL, mitochondria, and the endoplasmic reticulum .

Biological Functions

Primary Biological Functions: Paraoxonases play crucial roles in protecting against oxidative stress, inflammation, and atherosclerosis . They exhibit anti-inflammatory, anti-oxidative, anti-atherogenic, anti-diabetic, anti-microbial, and organophosphate-hydrolyzing properties .

Role in Immune Responses and Pathogen Recognition: Paraoxonases, particularly PON1, are involved in the innate immune system by hydrolyzing toxic metabolites and preventing oxidative damage . PON2 has been shown to protect against bacterial infections due to its high expression in human keratinocytes .

Modes of Action

Mechanisms with Other Molecules and Cells: Paraoxonases interact with various molecules and cells through their enzymatic activities. PON1, for example, hydrolyzes lactones and aryl esters, utilizing a catalytic calcium ion to stabilize substrate and reaction states .

Binding Partners and Downstream Signaling Cascades: PON1 associates with HDL in the bloodstream, contributing to its antioxidant properties by preventing the oxidation of low-density lipoproteins (LDL) . PON2 and PON3 also exhibit lactonase activity, which is crucial for their protective roles against oxidative stress .

Regulatory Mechanisms

Regulatory Mechanisms Controlling Expression and Activity: The expression and activity of paraoxonases are regulated at multiple levels, including transcriptional regulation and post-translational modifications . Factors such as oxidative stress, inflammation, and genetic polymorphisms can influence paraoxonase activity .

Transcriptional Regulation and Post-Translational Modifications: Transcriptional regulation of paraoxonase genes involves various transcription factors and regulatory elements. Post-translational modifications, such as phosphorylation and glycosylation, can also modulate enzyme activity .

Applications

Biomedical Research: Paraoxonases are studied for their roles in cardiovascular diseases, diabetes, and neurodegenerative disorders . Their antioxidant and anti-inflammatory properties make them potential targets for therapeutic interventions .

Diagnostic Tools: PON1 activity is used as a biomarker for oxidative stress and cardiovascular diseases . Measuring paraoxonase activity can help in diagnosing and monitoring these conditions .

Therapeutic Strategies: Enhancing paraoxonase activity through drugs, nutrients, and plant extracts is being explored as a therapeutic strategy to prevent and treat diseases associated with oxidative stress and inflammation .

Role in the Life Cycle

Role Throughout the Life Cycle: Paraoxonases play essential roles from development to aging and disease. During development, they protect against oxidative stress and inflammation . In aging, decreased paraoxonase activity is associated with increased susceptibility to diseases such as atherosclerosis and neurodegeneration .

From Development to Aging and Disease: Paraoxonases contribute to maintaining cellular homeostasis and protecting against environmental toxins throughout the life cycle . Their roles in various diseases highlight their importance in health and disease management .

© Copyright 2024 Thebiotek. All Rights Reserved.